Breaking News Instant updates and real-time market news.

BIIB

Biogen

$229.89

1.15 (0.50%)

06:46
04/24/19
04/24
06:46
04/24/19
06:46

Biogen CEO 'deeply disappointed' with discontinuation of aducanumab for AD

"Biogen delivered strong financial results in the first quarter driven by the solid operational performance of our MS, SMA, and biosimilars franchises," said Michel Vounatsos, Biogen's CEO. "However, we are deeply disappointed with the discontinuation of aducanumab for Alzheimer's disease. We followed the science, and unfortunately the outcome was not as we had hoped. We continue to believe we can create value for patients and investors by capitalizing on opportunities in neuroscience, and we remain focused on allocating capital to the areas we believe have the highest potential return for shareholders."

  • 24

    Apr

  • 30

    Apr

  • 01

    May

  • 04

    May

  • 29

    May

BIIB Biogen
$229.89

1.15 (0.50%)

03/26/19
PIPR
03/26/19
NO CHANGE
Target $280
PIPR
Overweight
Piper continues to recommend Biogen shares after deeper dive on BIIB067
Piper Jaffray analyst Christopher Raymond continues to recommend Biogen shares after a deeper dive on BIIB067, an anti-sense oligonucleotide targeting SOD1 for the treatment of SOD1-amyotrophic lateral sclerosis. With the recent discontinuation of aducanumab in mild Alzheimer's disease, the company's amyotrophic lateral sclerosis anti-sense oligonucleotide programs could help dispel the notion that Biogen has no pipeline, Raymond tells investors in a research note. He thinks the BIIB067 and BIIB078 programs could add $10 and $15, respectively, to the stock if successful. Raymond keeps an Overweight rating on Biogen with a $280 price target. The stock closed yesterday up $3.55 to $220.26.
04/02/19
PIPR
04/02/19
NO CHANGE
PIPR
Overweight
Piper says AAN meeting should be 'meaningful' for Alexion, Biogen
Piper Jaffray analyst Christopher Raymond reported that the American Academy of Neurology posted emerging science abstract titles this morning, adding that full abstracts are not anticipated until May 3. It appears Phase 3 data on Alexion's (ALXN) Soliris for Neuromyelitis Optica Spectrum Disorder, or NMOSD, will be presented as an emerging science abstract and that data from a Phase 1/2 study of Biogen's (BIIB) BIIB067 in SOD1 mutant ALS patients will also be presented, making the meeting potentially "meaningful" for both. Raymond keeps Overweight ratings on Alexion and Biogen.
04/10/19
RAJA
04/10/19
INITIATION
RAJA
Market Perform
Biogen resumed with a Market Perform at Raymond James
Raymond James analyst Steven Seedhouse resumed coverage of Biogen with a Market Perform rating, stating that the company's remaining business following the failure of aducanumab "appears a little fragile" and faces "existential risk" in some cases, such as the Tecfidera IPR decision due in 2020. Near-term pipeline readouts, including the nearest readouts on Vumerity and BIIB067, don't seem high-impact enough to reverse sentiment, Seedhouse tells investors.
04/11/19
BERN
04/11/19
INITIATION
Target $48
BERN
Outperform
PTC Therapeutics initiated with an Outperform at Bernstein
Bernstein analyst Vincent Chen started coverage on PTC Therapeutics (PTCT) with an Outperform rating and a $48 price target, given his positive view on the commercial potential of risdiplam in SMA. The analyst believes that there will still be a substantial market opportunity for non-gene therapy drugs after approval, and thinks risdiplam's oral dosing will be a substantial advantage over Biogen (BIIB) Spinraza's intrathecal administration. If risdiplam is safe and comparably efficacious to Spinraza, Chen forecasts potential for $2.5B in revenues by 2030.

TODAY'S FREE FLY STORIES

TRP

TC Pipeline

$48.93

0.15 (0.31%)

09:15
06/27/19
06/27
09:15
06/27/19
09:15
Hot Stocks
TC Energy launches binding open season for Keystone Pipeline System »

TC Energy Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOM

Exxon Mobil

$76.59

0.31 (0.41%)

09:15
06/27/19
06/27
09:15
06/27/19
09:15
Hot Stocks
Exxon Mobil, Global Thermostat to develop carbon dioxide capturing technology »

Exxon Mobil and Global…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:15
06/27/19
06/27
09:15
06/27/19
09:15
General news
The unrevised 3.1% U.S. Q1 GDP growth figure »

The unrevised 3.1% U.S.…

VISI

Volt Information Sciences

$4.40

0.12 (2.80%)

09:14
06/27/19
06/27
09:14
06/27/19
09:14
Hot Stocks
Volt Information Sciences names Lori Schultz Chief Global Solutions Officer »

Volt Information Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DXC

DXC Technology

$53.61

-0.41 (-0.76%)

09:14
06/27/19
06/27
09:14
06/27/19
09:14
Hot Stocks
DXC Technology, Zafin partner to help banks manage conduct risk »

DXC Technology and Zafin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BWAY

Brainsway

$10.21

-0.08 (-0.78%)

09:13
06/27/19
06/27
09:13
06/27/19
09:13
Hot Stocks
Psychiatrist debuts BrainsWay's FDA-cleared treatment for MDD, OCD »

Dr. Fabian Carbonell is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZM

Zoom Video

$86.15

1.27 (1.50%)

, VZ

Verizon

$57.00

-1.01 (-1.74%)

09:10
06/27/19
06/27
09:10
06/27/19
09:10
Hot Stocks
Zoom Video, Verizon partner for unified communications solution »

Verizon Business Group…

ZM

Zoom Video

$86.15

1.27 (1.50%)

VZ

Verizon

$57.00

-1.01 (-1.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 09

    Jul

  • 01

    Aug

BASFY

BASF

$0.00

(0.00%)

09:10
06/27/19
06/27
09:10
06/27/19
09:10
Hot Stocks
BASF announces restructuring, to cut 6,000 positions by end of 2021 »

BASF announced an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

09:10
06/27/19
06/27
09:10
06/27/19
09:10
General news
U.S. equities have trimmed overnight gains »

U.S. equities have…

ASV

ASV Holdings

$1.64

-0.11 (-6.29%)

, TEX

Terex

$30.76

-0.245 (-0.79%)

09:09
06/27/19
06/27
09:09
06/27/19
09:09
Hot Stocks
ASV Holdings enters definitive merger agreement with Yanmar affiliate »

ASV Holdings (ASV)…

ASV

ASV Holdings

$1.64

-0.11 (-6.29%)

TEX

Terex

$30.76

-0.245 (-0.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDLZ

Mondelez

$54.21

-1.01 (-1.83%)

09:08
06/27/19
06/27
09:08
06/27/19
09:08
Hot Stocks
Mondelez announces renewable energy partnership with Enel Green Power »

Mondelez International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEUM

Pareteum

$2.01

-0.49 (-19.60%)

09:07
06/27/19
06/27
09:07
06/27/19
09:07
Recommendations
Pareteum analyst commentary at Lake Street »

Pareteum fundamentals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 17

    Jul

  • 17

    Jul

  • 12

    Sep

LUNA

Luna Innovations

$4.26

0.06 (1.43%)

, HSC

Harsco

$27.13

0.54 (2.03%)

09:07
06/27/19
06/27
09:07
06/27/19
09:07
Conference/Events
Singular Research to hold a conference »

Summer Solstice New York…

LUNA

Luna Innovations

$4.26

0.06 (1.43%)

HSC

Harsco

$27.13

0.54 (2.03%)

DAKT

Daktronics

$5.99

(0.00%)

ACU

Acme United

$21.20

-0.62 (-2.84%)

CMTL

Comtech

$28.00

0.52 (1.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 12

    Sep

BASFY

BASF

$0.00

(0.00%)

09:07
06/27/19
06/27
09:07
06/27/19
09:07
Hot Stocks
Breaking Hot Stocks news story on BASF »

BASF announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

BSQR

Bsquare Corp

$1.23

-0.01 (-0.81%)

09:06
06/27/19
06/27
09:06
06/27/19
09:06
Hot Stocks
Bsquare Corp selected by Arcus FM in the U.K. »

Bsquare announced an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADMP

Adamis Pharmaceuticals

$1.29

0.03 (2.38%)

09:05
06/27/19
06/27
09:05
06/27/19
09:05
Hot Stocks
Adamis Pharmaceuticals files two motions, lawsuit in response to kaleo suit »

Adamis Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

FDX

FedEx

$159.92

3.92 (2.51%)

09:04
06/27/19
06/27
09:04
06/27/19
09:04
Recommendations
FedEx analyst commentary  »

FedEx price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 31

    Jul

  • 17

    Sep

  • 13

    Nov

OSTK

Overstock.com

$13.54

2.765 (25.66%)

09:03
06/27/19
06/27
09:03
06/27/19
09:03
Hot Stocks
Overstock.com subsidiary tZERO launches crypto wallet mobile app »

Overstock.com announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YEXT

Yext

$18.98

-0.36 (-1.86%)

09:03
06/27/19
06/27
09:03
06/27/19
09:03
Hot Stocks
Yext and Hootsuite launch platform integration for customer reviews »

Yext announced a new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

YEXT

Yext

$18.98

-0.36 (-1.86%)

09:03
06/27/19
06/27
09:03
06/27/19
09:03
Hot Stocks
Yext and Hootsuite launch platform integration for customer reviews »

Yext announced a new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

F

Ford

$9.90

0.06 (0.61%)

09:01
06/27/19
06/27
09:01
06/27/19
09:01
Hot Stocks
Ford to cut 12,000 jobs in Europe by end of 2020 »

Ford said in a statement…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jul

  • 24

    Jul

  • 23

    Oct

VBLT

VBL Therapeutics

$1.17

-0.01 (-0.85%)

09:01
06/27/19
06/27
09:01
06/27/19
09:01
Initiation
VBL Therapeutics initiated  »

Oppenheimer bullish on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OVID

Ovid Therapeutics

$1.79

-0.04 (-2.19%)

09:01
06/27/19
06/27
09:01
06/27/19
09:01
Hot Stocks
Ovid Therapeutics expects interim data from ENDYMION trial in Q3 »

Ovid continues to enroll…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OVID

Ovid Therapeutics

$1.79

-0.04 (-2.19%)

09:00
06/27/19
06/27
09:00
06/27/19
09:00
Hot Stocks
Ovid Therapeutics expects Phase 2 ROCKET trial results year-end or early 2020 »

The Phase 2 ROCKET trial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:00
06/27/19
06/27
09:00
06/27/19
09:00
General news
Treasury Action: the markets were little changed on the data »

Treasury Action: the…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.